VistaGen Therapeutics Inc... (VTGN)
NASDAQ: VTGN
· Real-Time Price · USD
2.21
-0.10 (-4.54%)
At close: Jun 13, 2025, 3:59 PM
2.30
4.07%
After-hours: Jun 13, 2025, 05:09 PM EDT
-4.54% (1D)
| Bid | 2.2 |
| Market Cap | 63.79M |
| Revenue (ttm) | 698.3K |
| Net Income (ttm) | -47.3M |
| EPS (ttm) | -1.48 |
| PE Ratio (ttm) | -1.49 |
| Forward PE | -1.38 |
| Analyst | n/a |
| Ask | 2.39 |
| Volume | 159,495 |
| Avg. Volume (20D) | 131,665 |
| Open | 2.29 |
| Previous Close | 2.31 |
| Day's Range | 2.18 - 2.36 |
| 52-Week Range | 1.90 - 4.21 |
| Beta | 0.69 |
About VTGN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol VTGN
Website n/a
Next Earnings Release
VistaGen Therapeutics Inc. is scheduled to release its earnings on Jun 17, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago · businesswire.com
Vistagen to Present at the 2025 Anxiety and Depression Association ConferenceSOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vistagen (Nasdaq: VTGN), a clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize...